摘要 |
The present invention provides methods of treating a range of T-cell mediated disease states in a subject. The methods involve administering to the subject a composition comprising a therapeutically effective amount of a polyunsaturated fatty acid and a pharmaceutically acceptable carrier; in which the plyunsaturated fatty acid contains 18-25 carbons, 1-6 double bonds and has one or two substitutions selected from the group consisting of beta oxa, gamma oxa, beta thia and gamma thia, or the polyunsaturated fatty acid contains 16-26 carbon chain, 3-6 double bonds and is covalently coupled at the carbolxylic acid group to an amino acid.
|
申请人 |
PEPTIDE TECHNOLOGY PTY. LIMITED;WOMEN'S AND CHILDREN'S HOSPITAL ADELAIDE;FERRANTE, ANTONIO;POULOS, ALFRED;PITT, MICHAEL, JOSEPH;EASTON, CHRISTOPHER, JOHN;SLEIGH, MERILYN, JOY;RATHJEN, DEBORAH, ANN;WIDMER, FRED |
发明人 |
FERRANTE, ANTONIO;POULOS, ALFRED;PITT, MICHAEL, JOSEPH;EASTON, CHRISTOPHER, JOHN;SLEIGH, MERILYN, JOY;RATHJEN, DEBORAH, ANN;WIDMER, FRED |